Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

When Young Men Are Scarce, They're More Likely To Play The Field Than To Propose
In places where young women outnumber young men, research shows the hemlines rise but the marriage rates don"t because the young men feel less pressure to settle down as more women compete for their affections.
generic viagra online
FDA Appointed Arthritis Advisory Committee Recommends U.S. Food And Drug Administration Approval For KRYSTEXXA(TM) For Refractory Chronic Gout
Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) announced that the Arthritis Advisory Committee appointed by the U.S. Food and Drug Administration (FDA) recommended by a vote of 14 to 1 that KRYSTEXXA(TM) (pegloticase), a biologic PEGylated uricase enzyme, be granted marketing approval by the FDA for the treatment of refractory chronic gout. Refractory chronic gout or treatment failure gout (TFG) is gout in patients who have failed to normalize serum uric acid and whose signs and symptoms are inadequately controlled with conventional urate-lowering therapy at the maximum medically appropriate dose or for whom conventional urate-lowering therapy is contraindicated. The current target Prescription Drug User Fee (PDUFA) action date for the FDA"s decision as to whether to grant marketing approval for KRYSTEXXA is August 1, 2009.
News of the day
What Are Bed Bugs? How To Kill Bed Bugs
Bed bugs, known scientifically as Cimex lectularius (Cimicidae) are small wingless insects that feed by hematophagy - exclusively on the blood of warm blooded-animals. As we are warm-blooded animals we are ideal hosts for them. Over millions of years bed bugs have evolved as nest parasites - inhabiting the nests of birds and the roosts of bats. Some of them have learnt to adapt to the human environment and live in our nests, i.e. our homes, and more specifically, our beds. Newborns, called hatchlings or nymphs, are tiny, about the size of a poppy seed, while adults grow to about Βά of an inch long. Their shape is oval and flattened. Both nymphs, eggs and adults are visible to the naked eye.
Diagnostics

World Hepatitis Day 2009: 5 Years For The EU To Rescue The Liver!

On the occasion of World Hepatitis Day and on the eve of the European Parliament elections, healthcare professionals and patients call on EU decision-makers to make the next 5 years about protecting the liver! Dr. Heiner Wedemeyer, Secretary General of the European Association for the Study of the Liver (EASL) and Nadine Piorkowsky, President of the European Liver Patients" Association (ELPA) urged EU decision-makers to save the lives of millions of Europeans and make liver diseases an EU health priority over the next five years: "We are witnessing an alarming trend in the number of people affected by liver diseases in the EU: every year, liver cancer causes approximately 700,000 deaths. Hepatitis B and C alone are estimated to affect more than 20 million people in the wider WHO European region and are on the rise in many EU countries" - said Dr. Heiner Wedemeyer, Secretary General of EASL. "A strong EU voice on liver disease is particularly needed because liver disease is often killing patients "silently": for years, and sometimes decades, patients do not feel the symptoms of their illness and therefore remain undiagnosed until it is too late. Targeted screening of those at risk of catching viral Hepatitis will contribute to defusing this "viral time bomb" and reducing Hepatitis-related morbidity and mortality in Europe" - added Nadine Piorkowsky, President of ELPA and a former Hepatitis C patient herself. EASL and ELPA call for four key EU measures that should be achieved over the next five years: - To adopt an EU Council Recommendation on viral Hepatitis Screening to further hepatitis prevention, surveillance, screening and care in Europe, promote cooperation among Member States and encourage the adoption and implementation of best practices in the area of liver diseases. - To increase EU research funding for liver diseases by including adequate calls for proposals on liver diseases, such as viral hepatitis, liver cancer, cirrhosis, fatty liver and others, in the European Commission"s Research Framework Programme - To develop and promote independent public awareness campaigns aimed at informing citizens about liver disease and how it can be prevented and treated - To improve monitoring and surveillance of liver diseases in the EU by stepping up the work of the European Centre for Disease prevention and Control (ECDC) About liver disease The liver is the body"s largest internal organ and is essential to life. It performs over 500 different functions for the body including processing digested food from the intestine and controlling levels of fats, amino acids and glucose in the blood. The liver"s complexity makes it susceptible to many different diseases, including among others: - Hepatitis - the most common liver disease which causes inflammation of the liver. It can occur in both viral (e.g. Hepatitis A, B, C, D, E) and non-viral forms (e.g. alcoholic and autoimmune hepatitis) and may result in an acute or chronic condition. - Cirrhosis - the excessive development of scar tissue within the liver which can lead to complete liver failure. This is the result of long-term, continuous damage to the organ. - Fatty liver - covers a range of conditions where there is a build-up of fat in the liver cells. It is caused by certain chemical compounds (particularly alcohol) and by nutritional and endocrine disorders. - Liver cancer - may occur as both primary (cancer that starts in the liver) and secondary (cancer that first develops elsewhere in the body and then spreads to the liver) - Genetic diseases - includes conditions such as Haemochromatosis, Wilson"s Disease and Glibert"s Syndrome. Most (but not all) of these diseases are rare (with a prevalence of less than 50 per 100,000 people). Although the liver is unique in its ability to regenerate it cannot survive continuous damage. About EASL EASL is the leading pan-European association of medical professionals dedicated to promoting liver research and care. Through its work, EASL aims to promote the education of physicians and scientists as well as to improve public awareness on liver diseases and their management. For more information on EASL, see http://www.easl.ch. ELPA


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009